We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ergomed Plc | LSE:ERGO | London | Ordinary Share | GB00BN7ZCY67 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,346.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMERGO
RNS Number : 6200D
Ergomed plc
01 February 2018
Ergomed Plc
("Ergomed" or the "Company")
Directors' Dealing
Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 1 February 2018, Mr Peter George, Chairman of the Company, bought 500,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share from Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company. Separately, in response to excess demand from the placing announced by the Company this morning, Dr Miroslav Reljanovic sold an additional 2,000,000 Shares at a price of 190p.
Following these transactions, Mr Peter George holds 776,250 shares (representing 1.8 per cent. of the Company's issued share capital and 1.7 per cent. of the Company's issued share capital following admission of the Placing Shares relating to the Placing announced by the Company earlier this morning) and Dr Miroslav Reljanovic's holding has reduced to 15,132,237 shares (representing 35.5 per cent. of the Company's issued share capital and 33.8 per cent. of the Company's issued share capital following admission of the Placing Shares relating to the Placing announced by the Company earlier this morning).
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities/person closely associated ---- ----------------------------------------------------------------------------- a) Name 1) Peter George 2) Dr Miroslav Reljanovic ---- ---------------------------- ----------------------------------------------- 2 Reason for the notification ---- ----------------------------------------------------------------------------- a) Position/status 1) Chairman 2) Founder and Executive Vice-Chairman ---- ---------------------------- ----------------------------------------------- b) Initial notification Initial Notification /Amendment ---- ---------------------------- ----------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---- ----------------------------------------------------------------------------- a) Name Ergomed Plc ---- ---------------------------- ----------------------------------------------- b) Legal Entity 213800BVS8I9VMC1AP84 Identifier ---- ---------------------------- ----------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---- ----------------------------------------------------------------------------- a) Description Ordinary shares of 1 pence each of the financial instrument, type of instrument GB00BN7ZCY67 Identification code ---- ---------------------------- ----------------------------------------------- b) Nature of 1) Purchase of shares the transaction 2) Sale of shares ---- ---------------------------- ----------------------------------------------- c) Currency GBP ---- ---------------------------- ----------------------------------------------- d) Price(s) and Price(s) Volume(s) volume(s) ---- ---------------------------- ---------------------- ----------------------- 190p 500,000 --------------------------------- ---------------------- ----------------------- 190p 2,500,000 --------------------------------- ---------------------- ----------------------- e) Aggregated information 1) 500,000 - Aggregated 2) 2,500,000 volume - Price 1) 190p - Aggregated 2) 190p total 1) GBP950,000.00 2) GBP4,750,000.00 ---- ---------------------------- ----------------------------------------------- f) Date of the 1 February 2018 transaction ---- ---------------------------- ----------------------------------------------- g) Place of the London Stock Exchange, AIM transaction ---- ---------------------------- -----------------------------------------------
Enquiries:
Ergomed plc Tel: +44 (0) 1483 503205 Stephen Stamp (Chief Executive Officer) Numis Securities Limited Tel: +44 (0) 20 7260 1000 Michael Meade / Freddie Barnfield (Nominated Adviser) James Black (Joint Broker)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEANAFEDSPEEF
(END) Dow Jones Newswires
February 01, 2018 04:39 ET (09:39 GMT)
1 Year Ergomed Chart |
1 Month Ergomed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions